Loại tài liệu:    Chỉ tìm trong: 
Tìm được 20 kết quả
Lenvatinib plus immunotherapy versus lenvatinib monotherapy in lenvatinib-insensitive patients with unresectable hepatocellular carcinoma: a retrospective study
Tác giả: Zeyu Yu, Lingfeng Diao, Bin Leng, Chendong Wang, Qingyu Xu, Guowen Yin, Ran You
Xuất bản: United States: Investigational new drugs , 2025
Bộ sưu tập: NCBI
ddc:  343.09482
 
Lenvatinib plus immunotherapy versus lenvatinib monotherapy in lenvatinib-insensitive patients with unresectable hepatocellular carcinoma: a retrospective study
Tác giả: Zeyu Yu, Bin Leng, Ran You, Chendong Wang, Lingfeng Diao, Qingyu Xu, Guowen Yin
Xuất bản: United States: Investigational new drugs , 2025
Bộ sưu tập: NCBI
ddc:  343.09482
 
Lenvatinib Monotherapy Versus Lenvatinib in Combination with PD-1 Blockades as Re-Challenging Treatment for Patients with Metastatic Osteosarcoma: A Real-World Study
Tác giả: Guohui Song, Qinglian Tang, Jinchang Lu, Huaiyuan Xu, Anqi Wang, Chuangzhong Deng, Hao Wu, Jinxin Hu, Xiaojun Zhu, Jin Wang
Xuất bản: New Zealand: Drug design, development and therapy , 2025
Bộ sưu tập: NCBI
ddc:  133.5266
 
Efficacy and safety of lenvatinib in a case of thymic carcinoma complicated with interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis
Tác giả: Yuki Hatakeyama, Jun Sakakibara-Konishi, Satoshi Konno, Masato Tarumi, Kosuke Tsuji, Hirofumi Takahashi, Megumi Furuta, Yuta Takashima, Hidenori Kitai, Tetsuaki Shoji, Yasuyuki Ikezawa
Xuất bản: England: Respiratory medicine case reports , 2025
Bộ sưu tập: NCBI
ddc:  069.50289
 
Comparative Efficacy of Lenvatinib Plus Immunotherapy and Regorafenib Plus Immunotherapy After Lenvatinib Failure for Advanced Hepatocellular Carcinoma: A Retrospective Study
Tác giả: Zeyu Yu, Bin Leng, Ran You, Lingfeng Diao, Qingyu Xu, Guowen Yin
Xuất bản: Switzerland: Drugs - real world outcomes , 2025
Bộ sưu tập: NCBI
ddc:  230.0071
 
Mechanistic insights of lenvatinib: enhancing cisplatin sensitivity, inducing apoptosis, and suppressing metastasis in bladder cancer cells through EGFR/ERK/P38/NF-κB signaling inactivation
Tác giả: Chih-Hung Chiang, Jr-Di Yang, Wei-Lin Liu, Fang-Yu Chang, Che-Jui Yang, Kai-Wen Hsu, I-Tsang Chiang, Fei-Ting Hsu
Xuất bản: England: Cancer cell international , 2025
Bộ sưu tập: NCBI
ddc:  025.486
 
Real-world outcomes of lenvatinib therapy for advanced neuroendocrine neoplasms
Tác giả: Joao Paulo Solar Vasconcelos, Jose Eduardo Nunez Rodriguez, John Paul McGhie, Howard Lim, Simron Singh, Jonathan M Loree, Ali Zaidi, Tharani Krishnan, Helia Jafari, Sharlene Gill, Ann Tan, Dan Le, Theresa Chan, Simon Yu
Xuất bản: England: Endocrine-related cancer , 2025
Bộ sưu tập: NCBI
ddc:  610.736
 
Lenvatinib suppress FGF19-FGFR4 signaling to enhance antitumor immune response in gastric cancer
Tác giả: Yuya Maruyama, Motonobu Saito, Tomoyuki Momma, Kosaku Mimura, Akiteru Goto, Koji Kono, Shotaro Nakajima, Katsuharu Saito, Hiroya Suzuki, Ryo Kanoda, Hirokazu Okayama, Hiroyuki Hanayama, Wataru Sakamoto, Zenichiro Saze
Xuất bản: Japan: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association , 2025
Bộ sưu tập: NCBI
ddc:  025.3177
 
Sensitive quantification of free lenvatinib using ultra-high performance liquid chromatography coupled to tandem mass spectrometry and the clinical significance of measuring free lenvatinib
Tác giả: Yoshio Sueshige, Ken Shiraiwa, Hiroki Itoh, Ryota Tanaka, Hironori Abe, Ryosuke Tatsuta, Tomoko Saito, Masao Iwao, Mizuki Endo, Mie Arakawa, Kazunari Murakami
Xuất bản: Netherlands: Clinica chimica acta; international journal of clinical chemistry , 2025
Bộ sưu tập: NCBI
ddc:  070.194
 
HAIC plus lenvatinib and tislelizumab for advanced hepatocellular carcinoma with Vp4 portal vein invasion
Tác giả: Shuangyan Tang, Feng Shi, Yi Xiao, Hongjie Cai, Ping Ma, Yuanmin Zhou, Zhiqiang Wu, Song Chen, Wenbo Guo
Xuất bản: United States: Hepatology international , 2025
Bộ sưu tập: NCBI
ddc:  553.453
 
1 2 Tiếp

Truy cập nhanh danh mục